AI assistant
Sending…
GENTEX CORP — Director's Dealing 2019
Oct 29, 2019
30893_dirs_2019-10-29_a2fa9d2e-9793-4435-b3c0-ff75287aa4f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2019-10-28
Reporting Person: GOODE GARY F (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-28 | Common Stock | M | 9414.00 | $12.365 | Acquired | 29817.00 | Direct |
| 2019-10-28 | Common Stock | S | 9414.00 | $28.101 | Disposed | 20403.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-10-28 | Employee Stock Option (Right to buy) | $12.365 | M | 9414.00 | Disposed | 2023-05-16 | Common Stock (9414.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $28.10 USD to $28.11 USD; the price reported above reflects the weighted average sale price.
F2: Options are fully vested.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19